SHAREHOLDERS' EQUITY (Details) (USD $) In Millions, except Share data, unless otherwise specified	0 Months Ended	3 Months Ended		9 Months Ended
	Jun. 24, 2013	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Increase (Decrease) in Shareholders' Equity
Beginning Balance (in shares)				333,036,637
Beginning Balance				$ 5,233.3	$ 3,717.4
Issuance of common stock (in shares)	27,058,824
Issuance of common stock	2,300.0				2,269.3
Common shares issued under share-based compensation plans				9.6	3.6
Repurchase of common shares					(55.6)
Settlement of stock options				(3.1)
Share-based compensation				60.6	32.5
Employee withholding taxes related to share-based awards				(38.5)	(35.9)
Tax benefits from stock options exercised				17.1	48.6
Noncontrolling interest from business combinations					113.5
Acquisition of noncontrolling interest				(3.3)
Noncontrolling interest distributions				(0.5)	(2.1)
Total before comprehensive income (loss)		5,275.2	6,091.3	5,275.2	6,091.3
Comprehensive loss:
Net income (loss)		276.4	(971.9)	378.1	(988.6)
Other comprehensive loss				(419.7)	(41.5)
Comprehensive loss		(169.7)	(788.9)	(41.6)	(1,030.1)
Beginning Balance (in shares)		334,004,879		334,004,879
Ending Balance		5,233.6	5,061.2	5,233.6	5,061.2
Common Shares
Increase (Decrease) in Shareholders' Equity
Beginning Balance (in shares)				333,000,000	303,900,000
Beginning Balance				8,301.2	5,940.7
Issuance of common stock (in shares)					27,100,000
Issuance of common stock					2,269.3
Common shares issued under share-based compensation plans (in shares)				1,000,000	2,500,000
Common shares issued under share-based compensation plans				33.2	64.2
Repurchase of common shares (in shares)					(700,000)
Repurchase of common shares					(14.2)
Total before comprehensive income (loss) (in shares)		334,000,000	332,800,000	334,000,000	332,800,000
Total before comprehensive income (loss)		8,334.4	8,260.0	8,334.4	8,260.0
Comprehensive loss:
Beginning Balance (in shares)		334,000,000	332,800,000	334,000,000	332,800,000
Ending Balance		8,334.4	8,260.0	8,334.4	8,260.0
Additional Paid-In Capital
Increase (Decrease) in Shareholders' Equity
Beginning Balance				228.8	267.1
Common shares issued under share-based compensation plans				(23.6)	(60.6)
Settlement of stock options				(3.1)
Share-based compensation				60.6	32.5
Employee withholding taxes related to share-based awards				(38.5)	(35.9)
Tax benefits from stock options exercised				17.1	48.6
Acquisition of noncontrolling interest				(1.1)
Total before comprehensive income (loss)		240.2	251.7	240.2	251.7
Comprehensive loss:
Ending Balance		240.2	251.7	240.2	251.7
Accumulated Deficit
Increase (Decrease) in Shareholders' Equity
Beginning Balance				(3,278.5)	(2,371.0)
Repurchase of common shares					(41.4)
Total before comprehensive income (loss)		(3,278.5)	(2,412.4)	(3,278.5)	(2,412.4)
Comprehensive loss:
Net income (loss)				378.6	(989.9)
Ending Balance		(2,899.9)	(3,402.3)	(2,899.9)	(3,402.3)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Shareholders' Equity
Beginning Balance				(132.8)	(119.4)
Total before comprehensive income (loss)		(132.8)	(119.4)	(132.8)	(119.4)
Comprehensive loss:
Other comprehensive loss				(419.2)	(40.9)
Ending Balance		(552.0)	(160.3)	(552.0)	(160.3)
Valeant Pharmaceuticals International, Inc. Shareholders’ Equity
Increase (Decrease) in Shareholders' Equity
Beginning Balance				5,118.7	3,717.4
Issuance of common stock					2,269.3
Common shares issued under share-based compensation plans				9.6	3.6
Repurchase of common shares					(55.6)
Settlement of stock options				(3.1)
Share-based compensation				60.6	32.5
Employee withholding taxes related to share-based awards				(38.5)	(35.9)
Tax benefits from stock options exercised				17.1	48.6
Acquisition of noncontrolling interest				(1.1)
Total before comprehensive income (loss)		5,163.3	5,979.9	5,163.3	5,979.9
Comprehensive loss:
Net income (loss)				378.6	(989.9)
Other comprehensive loss				(419.2)	(40.9)
Comprehensive loss				(40.6)	(1,030.8)
Ending Balance		5,122.7	4,949.1	5,122.7	4,949.1
Noncontrolling Interest
Increase (Decrease) in Shareholders' Equity
Beginning Balance				114.6
Noncontrolling interest from business combinations					113.5
Acquisition of noncontrolling interest				(2.2)
Noncontrolling interest distributions				(0.5)	(2.1)
Total before comprehensive income (loss)		111.9	111.4	111.9	111.4
Comprehensive loss:
Net income (loss)				(0.5)	1.3
Other comprehensive loss				(0.5)	(0.6)
Comprehensive loss				(1.0)	0.7
Ending Balance		$ 110.9	$ 112.1	$ 110.9	$ 112.1